Literature DB >> 6235243

A lymphoproliferative disorder of granular lymphocytes with a novel phenotype and suppressor function.

A Landay, M C Poon, L T Clement, C E Grossi.   

Abstract

In this study we have identified and characterized an expanded granular lymphocyte population in a patient with anemia and granulocytopenia. Granular lymphocytes were identified through the presence of cytoplasmic azurophilic granules, the dispersed granular pattern of cytochemical staining for acid hydrolases, and the ultrastructural localization of acid phosphatase within the granules. The surface phenotype of the granular lymphocytes was E+, FcR-, Leu 4+, Leu 2+, D 12+ (Leu 15+), OKM1+, and Leu 7+. This phenotype has not been reported previously in patients with similar features. Functional studies on FACS-purified populations showed that the patient's granular lymphocytes responded poorly to T-cell mitogens and were inefficient in NK and ADCC assays but exerted a potent suppressor effect on both T-cell proliferation and B-cell differentiation. The phenotype and functions of the expanded granular lymphocyte population correspond to those of a subset of normal E rosette-forming granular lymphocytes.

Entities:  

Mesh:

Year:  1984        PMID: 6235243     DOI: 10.1007/bf00915301

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  44 in total

1.  A low-viscosity epoxy resin embedding medium for electron microscopy.

Authors:  A R Spurr
Journal:  J Ultrastruct Res       Date:  1969-01

2.  Ultrastructural localization of alpha-naphthyl acid esterase in human TM lymphocytes.

Authors:  A Zicca; A Leprini; A Cadoni; A T Franzi; M Ferrarini; C E Grossi
Journal:  Am J Pathol       Date:  1981-10       Impact factor: 4.307

3.  Chronic T-cell lymphocytosis with neutropenia: report of a case studied with monoclonal antibody.

Authors:  A C Aisenberg; B M Wilkes; N L Harris; K A Ault; R W Carey
Journal:  Blood       Date:  1981-10       Impact factor: 22.113

4.  Proliferation of T gamma cells with killer-cell activity in patients with neutropenia.

Authors:  J C Brouet
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

5.  Large granular lymphocytes in human peripheral blood: ultrastructural and cytochemical characterization of the granules.

Authors:  C E Grossi; A Cadoni; A Zicca; A Leprini; M Ferrarini
Journal:  Blood       Date:  1982-02       Impact factor: 22.113

6.  Chronic lymphocytic leukaemia of T-cell origin. Immunological and clinical evaluation in eleven patients.

Authors:  J C Brouet; M Sasportes; G Flandrin; J L Preud'Homme; M Seligmann
Journal:  Lancet       Date:  1975-11-08       Impact factor: 79.321

7.  Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness.

Authors:  L Moretta; M Ferrarini; M C Mingari; A Moretta; S R Webb
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

8.  Proliferation of T gamma cells with killer-cell activity in two patients with neutropenia and recurrent infections.

Authors:  A A Bom-van Noorloos; H G Pegels; R H van Oers; J Silberbusch; T M Feltkamp-Vroom; R Goudsmit; W P Zeijlemaker; A E von dem Borne; C J Melief
Journal:  N Engl J Med       Date:  1980-04-24       Impact factor: 91.245

9.  Natural killer and suppressor T-cell chronic lymphocytic leukemia.

Authors:  M Palutke; L Eisenberg; J Kaplan; M Hussain; K Kithier; P Tabaczka; I Mirchandani; D Tenenbaum
Journal:  Blood       Date:  1983-09       Impact factor: 22.113

10.  Functional properties of T cells in patients with chronic T gamma lymphocytosis and chronic T cell neoplasia.

Authors:  H C Rümke; F Miedema; I J ten Berge; F Terpstra; H J van der Reijden; R J van de Griend; H G de Bruin; A E von dem Borne; J W Smit; W P Zeijlemaker; C J Melief
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

View more
  1 in total

1.  Immunophenotypical alterations in a subset of patients with common variable immunodeficiency (CVID).

Authors:  E Baumert; G Wolff-Vorbeck; M Schlesier; H H Peter
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.